Summaries of Must-Read Clinical Literature, Guidelines, and FDA Actions

Machine learning provides prognostic indicators for DLCBL recurrence

Publish date:: July 22, 2020

Key clinical point: Six variables were found to be significant indicators for recurrence in univariate and multivariate analysis.

Major finding: Disease stage, upper respiratory infection, serum lactate dehydrogenase, and beta-2 microglobulin were among the significant indicators for DLBCL recurrence.

Study details: A total of 52 variables were assessed in 518 patients with DLBCL.

Disclosures: The research was supported by a grant from the National Natural Science Foundation of China. The authors reported having no conflicts.

Citation:

Wang L et al. Computer Methods and Programs in Biomedicine. 2020; doi.org/10.1016/j.cmpb.2020.105567.

This Week's Must Reads

Younger adults present with more advanced esophageal adenocarcinoma,

PDAC: Tumor reduction after neoadjuvant therapy may predict postsurgical survival,

Mortality risks rise with age, infections, but not inhibitor status in persons with non-severe hemophilia A,

‘Impressive’ local control with MRI-guided brachytherapy in cervical cancer,

U.S. mothers underestimate role breastfeeding plays in curbing breast cancer,

Must Reads in DLBCL

Synthetic lethality: Triple combination is a viable strategy for B-cell malignancies,

Bispecific antibody odronextamab demonstrates durable complete responses in refractory NHL,

Survey quantifies COVID-19’s impact on oncology,

Sarcopenia is a predictor of overall survival in DLBCL patients,

Mutation tied to central nervous system collapse in DLBCL,